Key Details
Price
$1.04Annual ROE
-215.13%Beta
0.26Events Calendar
Next earnings date:
Feb 13, 2025Recent quarterly earnings:
Nov 13, 2024Recent annual earnings:
Sept 25, 2024Next ex-dividend date:
N/ARecent ex-dividend date:
N/ANext split:
N/ARecent split:
N/AAnalyst ratings
Recent major analysts updates
19 Nov '24 Benchmark
Speculative Buy01 Oct '24 Benchmark
Speculative Buy03 Oct '23 Benchmark
Speculative Buy25 Sept '23 HC Wainwright & Co.
Buy21 Sept '23 Maxim Group
Buy18 Sept '23 HC Wainwright & Co.
Buy18 May '23 Benchmark
Speculative Buy14 Feb '23 Benchmark
Speculative Buy27 July '22 Ladenburg Thalmann
Buy25 May '21 Benchmark
BuyMarket Data
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Dividend
Anebulo Pharmaceuticals doesn't have historical dividend data
Profitability
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Efficiency
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Valuation
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Liquidity
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cash Flow
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Institutional Ownership
Are Medical Stocks Lagging Anebulo Pharmaceuticals (ANEB) This Year?
ANEB
Zacks Investment Research19 October 2023
Here is how Anebulo Pharmaceuticals, Inc. (ANEB) and Conmed (CNMD) have performed compared to their sector so far this year.
Anebulo (ANEB) Gains on Positive FDA Response for ANEB-001
ANEB
Zacks Investment Research22 August 2023
Anebulo (ANEB) gains on positive FDA response for the phase III development of its lead candidate ANEB-001 for treating patients with acute cannabinoid intoxication.
Is Anebulo Pharmaceuticals (ANEB) Outperforming Other Medical Stocks This Year?
ANEB
Zacks Investment Research12 June 2023
Here is how Anebulo Pharmaceuticals, Inc. (ANEB) and Aquestive Therapeutics (AQST) have performed compared to their sector so far this year.
Has Anebulo Pharmaceuticals (ANEB) Outpaced Other Medical Stocks This Year?
ANEB
Zacks Investment Research24 May 2023
Here is how Anebulo Pharmaceuticals, Inc. (ANEB) and Ligand Pharmaceuticals (LGND) have performed compared to their sector so far this year.
FAQ
- What is the primary business of Anebulo Pharmaceuticals?
- What is the ticker symbol for Anebulo Pharmaceuticals?
- Does Anebulo Pharmaceuticals pay dividends?
- What sector is Anebulo Pharmaceuticals in?
- What industry is Anebulo Pharmaceuticals in?
- What country is Anebulo Pharmaceuticals based in?
- When did Anebulo Pharmaceuticals go public?
- Is Anebulo Pharmaceuticals in the S&P 500?
- Is Anebulo Pharmaceuticals in the NASDAQ 100?
- Is Anebulo Pharmaceuticals in the Dow Jones?
- When was Anebulo Pharmaceuticals's last earnings report?
- When does Anebulo Pharmaceuticals report earnings?
- Should I buy Anebulo Pharmaceuticals stock now?
What is the primary business of Anebulo Pharmaceuticals?
Anebulo Pharmaceuticals focuses on developing innovative treatments for addiction and related disorders. Their main goal is to create effective therapies that can help people overcome substance use issues, improving overall health and well-being. The company aims to address significant unmet medical needs in this area.
What is the ticker symbol for Anebulo Pharmaceuticals?
The ticker symbol for Anebulo Pharmaceuticals is NASDAQ:ANEB
Does Anebulo Pharmaceuticals pay dividends?
No, Anebulo Pharmaceuticals does not pay dividends
What sector is Anebulo Pharmaceuticals in?
Anebulo Pharmaceuticals is in the Healthcare sector
What industry is Anebulo Pharmaceuticals in?
Anebulo Pharmaceuticals is in the Biotechnology industry
What country is Anebulo Pharmaceuticals based in?
Anebulo Pharmaceuticals is headquartered in United States
When did Anebulo Pharmaceuticals go public?
Anebulo Pharmaceuticals's initial public offering (IPO) was on 07 May 2021
Is Anebulo Pharmaceuticals in the S&P 500?
No, Anebulo Pharmaceuticals is not included in the S&P 500 index
Is Anebulo Pharmaceuticals in the NASDAQ 100?
No, Anebulo Pharmaceuticals is not included in the NASDAQ 100 index
Is Anebulo Pharmaceuticals in the Dow Jones?
No, Anebulo Pharmaceuticals is not included in the Dow Jones index
When was Anebulo Pharmaceuticals's last earnings report?
Anebulo Pharmaceuticals's most recent earnings report was on 13 November 2024
When does Anebulo Pharmaceuticals report earnings?
The next expected earnings date for Anebulo Pharmaceuticals is 13 February 2025
Should I buy Anebulo Pharmaceuticals stock now?
As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions